Home> Products> 2 years

{ "products": [ { "_id": "6863d70eaf0c9d1aa0c2d3e5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "FLUTICATONE VILO 200", "description": "FLUTICATONE VILO 200 is a combination inhalation therapy containing Fluticasone Furoate (200 mcg), a potent corticosteroid, and Vilanterol (25 mcg), a long-acting beta2-adrenergic agonist (LABA). This fixed-dose inhalation powder is specially formulated to manage and prevent symptoms associated with chronic obstructive pulmonary disease (COPD) and asthma, helping patients breathe more easily and maintain better lung function.\n\nThis combination works synergistically—Fluticasone Furoate reduces inflammation and swelling in the airways, while Vilanterol relaxes the airway muscles, offering long-lasting bronchodilation. The once-daily dosing improves compliance and ensures consistent therapeutic effects throughout the day.\n\nWhat is Fluticasone Furoate and Vilanterol Powder for Inhalation?\nFluticasone Furoate and Vilanterol Powder for Inhalation is a prescription combination medication used for long-term maintenance treatment of asthma and COPD. It is not a rescue medicine and should not be used to relieve sudden breathing problems.\n\nFluticasone Furoate 200 mcg: A highly effective corticosteroid that helps to reduce inflammation in the lungs.\n\nVilanterol 25 mcg: A bronchodilator that keeps airways open by relaxing muscles around them for up to 24 hours.\n\nUses of Fluticasone Furoate and Vilanterol Powder for Inhalation\nLong-term treatment of moderate to severe asthma in adults and adolescents.\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.\n\nReduces the frequency of asthma attacks and COPD exacerbations.\n\nImproves overall lung function, quality of life, and exercise capacity in chronic airway diseases.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation uses\n\nSide Effects of Fluticasone Furoate and Vilanterol Powder for Inhalation\nWhile FLUTICATONE VILO 200 is generally well-tolerated, it may cause some side effects in certain individuals, especially during the initial phase of therapy. Common and less frequent side effects may include:\n\nHeadache\n\nHoarseness or voice changes\n\nSore throat\n\nCough or throat irritation\n\nFungal infection in the mouth (oral thrush)\n\nIncreased heart rate or palpitations\n\nMuscle cramps\n\nDizziness\n\nRespiratory tract infections\n\nSerious but rare effects include allergic reactions, paradoxical bronchospasm, and increased risk of pneumonia in COPD patients.\n\nKeyword integrated: fluticasone furoate and vilanterol powder for inhalation side effects\n\nPrecautions Before Using\nDo not use FLUTICATONE VILO 200 for acute asthma or COPD attacks. Always carry a fast-acting inhaler.\n\nInform your doctor if you have a history of heart disease, hypertension, thyroid problems, liver disorders, or tuberculosis.\n\nRinse your mouth after each use to avoid oral thrush.\n\nUse the inhaler as prescribed, and do not exceed the recommended dose.\n\nNot recommended for use in children under 12 years unless prescribed.\n\nInform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.\n\nDrug Interactions\nCertain medications may affect the way FLUTICATONE VILO 200 works or increase the risk of side effects. Consult your doctor if you are taking:\n\nBeta-blockers (e.g., atenolol, propranolol)\n\nDiuretics (may increase the risk of hypokalemia)\n\nMAO inhibitors or tricyclic antidepressants (can enhance the effect of Vilanterol)\n\nAntifungal or antiviral medications (e.g., ketoconazole, ritonavir) that may increase corticosteroid levels\n\nOther long-acting beta agonists (LABAs) or inhaled corticosteroids\n\nWhat drugs interact with Fluticasone Furoate and Vilanterol?\nFluticasone Furoate and Vilanterol may interact with:\n\nStrong CYP3A4 inhibitors (like ritonavir, itraconazole) leading to increased steroid effects\n\nBeta-adrenergic blockers which may reduce the efficacy of vilanterol\n\nXanthine derivatives, diuretics, or digoxin, which may lead to heart rhythm disturbances when combined\n\nConclusion\nFLUTICATONE VILO 200 offers an effective, once-daily treatment for asthma and COPD by combining the anti-inflammatory power of Fluticasone Furoate 200 mcg and the long-acting bronchodilation of Vilanterol 25 mcg. It not only helps maintain clear airways but also improves your overall breathing comfort and quality of life. For optimal results, use the inhaler consistently and under your healthcare provider’s guidance.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "24 hours", "increased risk", "drugs interact", "antiviral medications", "recommended dose", "airways open", "reduce inflammation", "acute asthma", "asthma attacks", "severe asthma", "copd attacks", "inhaler consistently", "optimal results", "breathing comfort", "longacting bronchodilation", "antiinflammatory power", "inhaled corticosteroids", "vilanterol antifungal", "tricyclic antidepressants", "taking betablockers", "prescribed inform", "tuberculosis rinse", "headache hoarseness", "initial phase", "generally welltolerated", "fluticatone vilo 200", "exercise capacity", "emphysema reduces", "chronic bronchitis", "relaxing muscles", "rescue medicine", "vilanterol relaxes", "prevent symptoms", "specially formulated", "vilanterol 25 mcg", "vilanterol powder", "rare effects", "ketoconazole ritonavir", "healthcare provider", "therapy common", "potent corticosteroid", "fluticasone furoate", "side effects", "lung function", "vilanterol fluticasone furoate", "copd exacerbations improves", "inhalation fluticasone furoate", "lung function quality", "fixeddose inhalation powder", "increase corticosteroid levels", "fastacting inhaler inform", "combination inhalation therapy", "side effects consult", "frequent side effects", "inhalation longterm treatment", "healthcare providers guidance", "ritonavir itraconazole leading", "highly effective corticosteroid", "effective oncedaily treatment", "heart rhythm disturbances", "strong cyp3a4 inhibitors", "hypokalemia mao inhibitors", "atenolol propranolol diuretics", "breastfeeding drug interactions", "pregnant planning pregnancy", "avoid oral thrush", "sore throat cough", "adolescents maintenance treatment", "longterm maintenance treatment", "prescription combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2140, "imageuri": "https://productimages.withfloats.com/actual/686785bc0500f068046215ba.png", "tileimageuri": "https://productimages.withfloats.com/tile/686785bc0500f068046215ba.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-01T12:39:42.59Z", "updatedon": "2025-07-04T07:41:47.804Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/fluticatone-vilo-200/2140", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "fluticasone furoate and vilanterol powder for inhalation", "category": "ASTHMARANGE", "tags": [ "fluticasone furoate and vilanterol powder for inhalation" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67eb8bd17f3ad6660cc7056c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Paracetamol IP (500 mg), Phenylephrine Hydrochloride IP (5 mg), Caffeine IP (30 mg), Diphenhydramine Hydrochloride IP (25 mg)", "description": "METAPECT COLD is a powerful combination medication designed to provide effective relief from common cold symptoms, including fever, nasal congestion, runny nose, and headaches. It contains a blend of Paracetamol IP (500 mg), Phenylephrine Hydrochloride IP (5 mg), Caffeine IP (30 mg), and Diphenhydramine Hydrochloride IP (25 mg) to combat multiple symptoms associated with cold and flu. This formulation works to alleviate pain, reduce fever, clear nasal congestion, and provide relief from sneezing and allergies.\n\n \nKey Benefits:\n \n\n Provides fast and effective relief from fever, body aches, and headaches\n Clears nasal congestion and promotes easier breathing\n Reduces sneezing, runny nose, and watery eyes caused by allergies\n Helps alleviate sinus pressure and discomfort\n Improves alertness and reduces drowsiness while relieving cold symptoms\n\n \nHow Does It Work?\n \n\nMETAPECT COLD works through its four active ingredients:\n\nParacetamol reduces fever and relieves pain by inhibiting certain pain-causing chemicals in the body.\nPhenylephrine acts as a decongestant, reducing swelling in the nasal passages for easier breathing.\nCaffeine enhances the effectiveness of paracetamol and helps reduce drowsiness.\nDiphenhydramine blocks histamines to relieve allergy-related symptoms such as a runny nose and sneezing.\n \nDirections for Use:\n \n\nTake 1 tablet every 4 to 6 hours as needed, or as directed by your healthcare provider.\nDo not exceed 4 doses in 24 hours.\nSwallow the tablet whole with a glass of water.\nCan be taken with or without food.\nNot recommended for children under 12 years of age.\n \nSide Effects:\n \n\nWhile METAPECT COLD is generally well-tolerated, some individuals may experience mild side effects, including:\n\nDrowsiness or dizziness\nNausea or upset stomach\nDry mouth\nIncreased heart rate\nRestlessness or difficulty sleeping\nIf any severe side effects occur, such as difficulty breathing, severe dizziness, or allergic reactions, seek medical attention immediately.", "price": 79.0, "discountamount": 24.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 years", "1 tablet", "6 hours", "24 hours swallow", "sneezing directions", "reduces drowsiness", "difficulty sleeping", "dizziness nausea", "generally welltolerated", "exceed 4 doses", "healthcare provider", "runny nose", "nasal passages", "paincausing chemicals", "relieves pain", "formulation works", "metapect cold", "effective relief", "provide relief", "provide effective relief", "relieving cold symptoms", "common cold symptoms", "age side effects", "relieve allergyrelated symptoms", "decongestant reducing swelling", "body phenylephrine acts", "discomfort improves alertness", "watery eyes caused", "fever body aches", "allergies key benefits", "combat multiple symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2076, "imageuri": "https://productimages.withfloats.com/actual/67eb8bd252099d3665ffd711.png", "tileimageuri": "https://productimages.withfloats.com/tile/67eb8bd252099d3665ffd711.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-01T06:46:41.199Z", "updatedon": "2025-04-03T10:22:11.187Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paracetamol-ip-500-mg-phenylephrine-hydrochloride-ip-5-mg-caffeine-ip-30-mg-diphenhydramine-hydrochloride-ip-25-mg-/2076", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT COLD", "category": "GENERAL RANGE", "tags": [ "पेरासिटामोल phenylephrine हाइड्रोक्लोराइड chlorpheniramine maleate", "Paracetamol+Phenylephrine hydrochloride Caffeine and diphenhydramine hydrochloride tablets uses", "Caffeine and Diphenhydramine hydrochloride tablets Uses in Hindi", "Paracetamol Phenylephrine hydrochloride Caffeine Diphenhydramine uses in tamil", "Paracetamol Phenylephrine Hydrochloride Caffeine Tablets", "METAPECT COLD" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666960ca8999680f14808b90", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CABRIZEPINE CR 200 ", "description": "CABRIZEPINE CR 200 \nCarbamazepine (200mg)\nIntroduction\nCABRIZEPINE CR 200 contains Carbamazepine (200mg) in a controlled-release formulation, designed to provide steady and prolonged therapeutic effects. Carbamazepine is a well-established medication used for the treatment of various types of seizures, trigeminal neuralgia, and bipolar disorder. This controlled-release form ensures consistent medication levels in the bloodstream, enhancing efficacy and reducing the risk of side effects.\n\nKey Ingredient and Its Benefits\nCarbamazepine (200mg)\nAntiepileptic Properties: Carbamazepine stabilizes hyperactive nerve membranes, reducing the likelihood of seizure occurrences.\nSeizure Control: It is effective in managing various types of seizures, including partial seizures with complex symptoms, generalized tonic-clonic seizures, and mixed seizure patterns.\nTrigeminal Neuralgia: Carbamazepine is the drug of choice for treating trigeminal neuralgia, a condition characterized by severe facial pain.\nMood Stabilizer: It is also used in the management of bipolar disorder, particularly for preventing manic episodes.\nBenefits of CABRIZEPINE CR 200\nEffective Seizure Management: CABRIZEPINE CR 200 provides robust control over various types of seizures, reducing their frequency and severity.\nPain Relief: It offers significant relief from the severe pain associated with trigeminal neuralgia.\nMood Stabilization: The medication helps stabilize mood swings in individuals with bipolar disorder, reducing the frequency and intensity of manic episodes.\nControlled Release: The controlled-release formulation ensures a steady release of medication, maintaining consistent therapeutic levels and enhancing patient compliance.\nDosage and Administration\nDosage\nSeizure Disorders: The typical starting dosage for adults and children over 12 years of age is 200mg twice daily. The dosage may be gradually increased by the healthcare provider based on the patient’s response and tolerability, with a typical maintenance dose ranging from 800mg to 1200mg per day.\nTrigeminal Neuralgia: The initial dose is typically 100mg to 200mg twice daily, gradually increased until pain relief is achieved. The maintenance dose usually ranges from 400mg to 800mg per day.\nBipolar Disorder: The dosage is individualized based on the patient’s response, typically starting with 200mg twice daily and adjusted as needed.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet, as it is designed for controlled release.\nConsistency: For optimal results, take CABRIZEPINE CR 200 at the same times each day to maintain consistent medication levels in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/cabrizepine-cr-200-134122", "price": 29.0, "discountamount": 8.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "risk", "drug", "200mg", "EMAIL", "water", "800mg", "400mg", "100mg", "choice", "adults", "tablet", "Oral Use", "response", "12 years", "children", "efficacy", "Benefits", "severity", "treatment", "intensity", "frequency", "condition", "likelihood", "same times", "full glass", "severe pain", "individuals", "bloodstream", "mood swings", "Pain Relief", "information", "Consistency", "sterispharma", "Introduction", "tolerability", "sterisonline", "side effects", "initial dose", "various types", "Carbamazepine", "CALL/WHATSAPP", "steady release", "CABRIZEPINE CR", "robust control", "manic episodes", "Key Ingredient", "Seizure Control", "optimal results", "Mood Stabilizer", "bipolar disorder", "partial seizures", "complex symptoms", "Seizure Disorders", "severe facial pain", "Controlled Release", "patient compliance", "Mood Stabilization", "significant relief", "healthcare provider", "seizure occurrences", "trigeminal neuralgia", "Administration Dosage", "mixed seizure patterns", "typical starting dosage", "Antiepileptic Properties", "typical maintenance dose", "hyperactive nerve membranes", "Effective Seizure Management", "consistent medication levels", "prolonged therapeutic effects", "consistent therapeutic levels", "controlled-release formulation", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1790, "imageuri": "https://productimages.withfloats.com/actual/667d12d8422dd0be26721b4b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d12d8422dd0be26721b4b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T08:48:10.533Z", "updatedon": "2024-06-27T07:37:51.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cabrizepine-cr-200-/1790", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CABRIZEPINE CR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "CABRIZEPINE CR 200 mg", "Carbamazepine 200mg", "Carbamazepine 200 mg uses", "Carbamazepine side effects", "Carbamazepine tablets", "Carbamazepine dose" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66695ccbcee93a1bbc381bb9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BVM GOLD 25 ", "description": "BVM GOLD 25 \nBrivaracetam (25mg)\nIntroduction\nBVM GOLD 25 contains Brivaracetam (25mg), an antiepileptic medication used for the treatment of partial-onset seizures in patients with epilepsy. Brivaracetam is highly effective in controlling seizures and is known for its rapid onset of action and favorable safety profile, making it a valuable choice for managing epilepsy and improving patients' quality of life.\n\nKey Ingredient and Its Benefits\nBrivaracetam (25mg)\nAntiepileptic Properties: Brivaracetam works by binding to synaptic vesicle protein 2A (SV2A) in the brain, helping to stabilize neural activity and prevent seizures.\nPartial-Onset Seizures: It is specifically effective in controlling partial-onset seizures, which originate in a specific area of the brain and can spread to other regions.\nRapid Onset of Action: Brivaracetam has a rapid onset of action, providing quick relief from seizures and reducing seizure frequency.\nWell-Tolerated: The medication is generally well-tolerated, with fewer side effects compared to other antiepileptic drugs.\nBenefits of BVM GOLD 25\nEffective Seizure Control: BVM GOLD 25 offers effective control of partial-onset seizures, reducing their frequency and severity.\nRapid Relief: The rapid onset of action ensures quick relief from seizures, improving the patient's immediate safety and comfort.\nImproved Quality of Life: By effectively managing seizures, BVM GOLD 25 helps enhance the overall quality of life for individuals with epilepsy, allowing them to lead more active and fulfilling lives.\nWell-Tolerated: Brivaracetam is well-tolerated, with a low incidence of side effects, making it suitable for long-term use.\nDosage and Administration\nDosage\nPartial-Onset Seizures: The typical starting dosage for partial-onset seizures in adults and adolescents aged 16 years and older is one tablet (25mg) taken twice daily. The dosage may be adjusted by the healthcare provider based on the patient's response and tolerability, with a maximum recommended dose of 100mg twice daily.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. It can be taken with or without food.\nConsistency: For optimal results, take BVM GOLD 25 at the same times each day to maintain an even level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/bvm-gold-25-133542", "price": 182.0, "discountamount": 54.6, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "food", "25mg", "SV2A", "Order", "EMAIL", "level", "water", "100mg", "brain", "action", "adults", "active", "comfort", "binding", "epilepsy", "bvm-gold", "severity", "BVM GOLD", "response", "Benefits", "Oral Use", "treatment", "full glass", "same times", "one tablet", "rapid onset", "information", "bloodstream", "Consistency", "adolescents", "individuals", "sterispharma", "tolerability", "sterisonline", "Brivaracetam", "Introduction", "Rapid Relief", "quick relief", "CALL/WHATSAPP", "other regions", "specific area", "long-term use", "low incidence", "Key Ingredient", "optimal results", "overall quality", "neural activity", "valuable choice", "Improved Quality", "immediate safety", "fulfilling lives", "effective control", "seizure frequency", "patients' quality", "fewer side effects", "healthcare provider", "Administration Dosage", "partial-onset seizures", "typical starting dosage", "maximum recommended dose", "antiepileptic medication", "favorable safety profile", "Antiepileptic Properties", "Effective Seizure Control", "other antiepileptic drugs", "synaptic vesicle protein 2A" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1784, "imageuri": "https://productimages.withfloats.com/actual/66695cce2d43284d727035d1.png", "tileimageuri": "https://productimages.withfloats.com/tile/66695cce2d43284d727035d1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T08:31:07.816Z", "updatedon": "2024-06-27T07:33:37.017Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bvm-gold-25-/1784", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BVM GOLD 25 ", "category": "NEUROLOGY RANGE", "tags": [ "BVM GOLD 25 PRICE", "BVM GOLD 25 USSES", "BVM GOLD 25 BENEFITS", "Brivaracetam (25mg)", "", "BVM GOLD 25", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c47c2bed1f08484d6c10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TAMOXIFILM 20 ", "description": "TAMOXIFILM 20 \nTamoxifen IP (20mg)\nTamoxifilm 20 contains Tamoxifen IP at a concentration of 20mg per dose. Tamoxifen is a medication commonly used in the treatment of breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs). Tamoxifen works by blocking the effects of estrogen in the breast tissue, thereby slowing down or stopping the growth of cancer cells that require estrogen to grow.\n\nTamoxifilm 20 is typically prescribed for:\n\nBreast Cancer: It is effective in both early-stage and advanced breast cancer cases. It may be used before surgery to reduce tumor size or after surgery to prevent the recurrence of cancer.\n\nPrevention: Tamoxifen is also used for reducing the risk of developing breast cancer in high-risk individuals, especially those with a family history of breast cancer or certain genetic mutations.\n\nHormone Receptor-Positive Breast Cancer: It is particularly beneficial for hormone receptor-positive breast cancers, where the cancer cells have receptors for estrogen or progesterone.\n\nMetastatic Breast Cancer: In cases where breast cancer has spread to other parts of the body, Tamoxifen can help in controlling the spread and managing the symptoms.\n\nUsage and Dosage:\n\nTamoxifilm 20 is usually taken orally, with or without food.\nThe typical dosage for breast cancer treatment is 20mg to 40mg daily, usually for 5 years or as directed by the healthcare provider.\nFor prevention purposes, the dosage may vary depending on individual risk factors and medical history.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/tamoxifilm-20-133689", "price": 32.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "dose", "20mg", "40mg", "food", "SERMs", "drugs", "Order", "Usage", "class", "Email", "spread", "growth", "surgery", "effects", "5 years", "WhatsApp", "symptoms", "receptors", "tumor size", "recurrence", "medication", "TAMOXIFILM", "information", "other parts", "early-stage", "sterispharma", "progesterone", "sterisonline", "cancer cells", "Tamoxifen IP", "breast tissue", "concentration", "family history", "typical dosage", "medical history", "genetic mutations", "healthcare provider", "prevention purposes", "high-risk individuals", "breast cancer treatment", "individual risk factors", "Metastatic Breast Cancer", "advanced breast cancer cases", "selective estrogen receptor modulators", "hormone receptor-positive breast cancers" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1511, "imageuri": "https://productimages.withfloats.com/actual/667d3e4b000f6c164f0965cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e4b000f6c164f0965cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:27:40.343Z", "updatedon": "2024-06-27T10:26:13.622Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tamoxifilm-20-/1511", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TAMOXIFILM 20 ", "category": "NEPHROLOGYRANGE", "tags": [ "", "tamoxifen 20 mg uses", "tamoxifen 20 mg dosage", "", "tamoxifen 20 mg side effects", "tamoxifen 20 mg brand name", "tamoxifen 20 mg buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66389dccedbab11d945a9caf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LEVECERTAIN 250 ", "description": "LEVECERTAIN 250 \nLevetiracetam (250mg)\nLevecertain 250 contains Levetiracetam, an antiepileptic medication used to control seizures in epilepsy. It works by stabilizing electrical activity in the brain. Levetiracetam is often prescribed to treat partial-onset seizures in adults and children over 4 years old, as well as myoclonic seizures in people with juvenile myoclonic epilepsy.\n\nThis medication is available in 250mg tablets and is typically taken orally, with or without food, as directed by a healthcare professional. The dosage may vary based on the patient's age, weight, medical condition, and response to treatment.\n\nCommon side effects of Levecertain 250 may include dizziness, drowsiness, weakness, headache, loss of appetite, and mood changes. It's essential to follow the prescribed dosage and consult a doctor if any severe side effects or allergic reactions occur.\n\nLevecertain 250 should not be stopped abruptly without consulting a doctor, as sudden discontinuation can increase the risk of seizures. It's important to take this medication regularly to maintain its effectiveness in controlling seizures and improving quality of life for patients with epilepsy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "life", "risk", "loss", "food", "brain", "doctor", "weight", "dosage", "people", "adults", "patient", "quality", "appetite", "headache", "weakness", "response", "children", "dizziness", "treatment", "drowsiness", "LEVECERTAIN", "mood changes", "Levetiracetam", "250mg tablets", "effectiveness", "medical condition", "allergic reactions", "myoclonic seizures", "electrical activity", "severe side effects", "Common side effects", "sudden discontinuation", "partial-onset seizures", "healthcare professional", "antiepileptic medication", "juvenile myoclonic epilepsy" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1142, "imageuri": "https://productimages.withfloats.com/actual/66389e0cc76b7398ff89147f.png", "tileimageuri": "https://productimages.withfloats.com/tile/66389e0cc76b7398ff89147f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-06T09:07:24.237Z", "updatedon": "2024-06-11T12:04:33.702Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/levecertain-250-/1142", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Levetiracetam (250mg)", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68bc22e83c3803d861d696a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 200", "description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.", "price": 185.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2173, "imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png", "tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-06T12:02:48.098Z", "updatedon": "2025-09-08T10:03:20.923Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefpodoxime Proxetil Tablets IP 200 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }